The new immunotherapy will be tested in humans as soon as possible (PRESS RELEASE) ZURICH, 8-May-2020 — /EuropaWire/ — University…
The EC approval is based on the first global CAR-T registration trials, which included patients from eight European countries and demonstrated durable…
Kymriah demonstrated an overall response rate of 50%, with median duration of response not yet reached at the time of…
ENESTnd data indicate trend for longer overall survival and event-free survival in newly diagnosed Ph+ CML patients on Tasigna versus…
The charity match is in support of Stiliyan Petrov 29-5-2013 — /europawire.eu/ — Fibank (First Investment Bank) has bought 1,000 tickets for…